Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the Voyage 1 Clinical Trial
AuthID
P-00Z-DQ9
P-00Z-DQ9
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service